Harvey EJ, Arroyo K, Korner J, Inabnet WB
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
Top Reasons Patients Stop GLP-1 Medications The research identified several major factors contributing to treatment discontinuation
Review links 3 potentially-blinding eye conditions to GLP-1 drugs like Ozempic
doi: 10.3389/fpsyt.2021.671151 Received 23 February 2021 Accepted 02 September 2021 Published 30 September 2021 Volume 12 - 2021 Edited by Agorastos Agorastos, Aristotle University of Thessaloniki, Greece Reviewed by Carla Nasca, The Rockefeller University, United States
This will be a great choice for anyone who wants to boost their strength and resistance to tiredness